Alvotech ALVO
NASDAQ ALVO
$4.43 +0.16 (+3.75%)
At close: Aug 21, 2026 · 4:00 PM EDT

Alvotech (ALVO) Asset Writedowns and Impairment (2021 - 2026)

Alvotech's (ALVO) quarterly Asset Writedowns and Impairment came in at $3.1 million in Q1 2026, up 345.63% YoY from $686000.0 in Q1 2025, and up 135.09% on a QoQ basis from -$8.7 million in Q4 2025.

Alvotech (ALVO) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has 5 years of Asset Writedowns and Impairment data on file, last reported at $3.1 million in Q1 2026.

  • Quarterly Asset Writedowns and Impairment rose 345.63% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 349.84% YoY) and the FY2023 annual result came in at $21.5 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment rose to $3.1 million in Q1 2026, from -$8.7 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $27.3 million in Q4 2022 to a low of -$8.7 million in Q4 2025.
  • A 4-year average of $2.2 million and a median of $686000.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
  • Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment soared 43450.79% — and 2025, when it slumped 150.16%.
  • Tracing ALVO's Asset Writedowns and Impairment over 4 years: stood at $27.3 million in 2022, then sank by 112.75% to -$3.5 million in 2024, then tumbled by 150.16% to -$8.7 million in 2025, then jumped by 135.09% to $3.1 million in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $3.1 million (Q1 2026), -$8.7 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Alvotech 1.30 Bn 1.30 Bn 5.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.06 Mn
Mar 31, 2026 3.06 Mn
Dec 31, 2025 -8.71 Mn
Dec 31, 2025 -8.71 Mn
Sep 30, 2025 3.48 Mn
Sep 30, 2025 3.48 Mn
Jun 30, 2025 4.55 Mn
Jun 30, 2025 4.55 Mn
Mar 31, 2025 686,000.00
Mar 31, 2025 686,000.00
Dec 31, 2024 -3.48 Mn
Dec 31, 2024 -3.48 Mn
Sep 30, 2024 3.41 Mn
Sep 30, 2024 3.41 Mn
Jun 30, 2024 -1.56 Mn
Jun 30, 2024 -1.56 Mn
Mar 31, 2024 -5.38 Mn
Mar 31, 2024 -5.38 Mn
Dec 31, 2022 27.31 Mn
Dec 31, 2022 27.31 Mn